Brain Tumor Research Program
The Brain Tumor Research Program is a multidisciplinary program that promotes collaborations among its members for laboratory research and treatment strategies for brain and spinal tumors. This program spans 14 departments and involves 70 research and clinical scientists who focus on discovering the molecular changes that drive brain and spinal tumors and developing effective new treatments for these devastating tumors.
The Brain Tumor Research Program supports interactions among its diverse group by sponsoring scientific retreats, meetings and collaborative projects.
Brain Tumor Research Program members participate in a Brain Cancer SPORE (Specialized Program of Research Excellence), funded by the National Cancer Institute (NCI), for the study of new brain tumor treatments. As one of the few cancer centers in the nation to house such an award, we are able to offer patients participation in a range of unique clinical trials.
Members are also major contributors to The Cancer Genome Atlas, a program funded by NCI and the National Human Genome Research Institute to accelerate the understanding of the genetics of cancer. Brain Tumor Research Program funding is used to supply additional support to priority projects, allowing them to become more productive.
Our intention is that the new knowledge generated by these partnerships will lead to improved detection of cancer, treatment for tumors and care for patients, as we train the next generation of clinicians and investigators.